40 ESTATE LN READING, MA 01867 Get Directions
40 ESTATE LN READING, MA 01867 Get Directions
Founded 2012
Incorporated MA
Annual Revenue $89,763.00
Employee Count 2
Industries Biotechnical Research, Commercial
Contacts Roger Frechette Frontiera Therapeutics is a privately-held company, established in 2012, focused on treatments for fluid leakage from blood vessels (vascular leak) - the underlying cause of multiple serious, often fatal, conditions. The first drug under development is a unique enzyme activator that strengthens the permeability barrier and blocks vascular leak.
The first product application of Frontiera's barrier augmentation technology is a truly transformational approach to a treatment for Acute Respiratory Distress syndrome (ARDS) a devastating, often fatal condition characterized by vascular leak. ARDS is a common complication of more than 60 medical conditions, including pneumonia, sepsis, aspiration, trauma, acute mountain sickness and burns. In the US, it is fatal for approximately 40% of diagnosed patients. The current standard treatment is limited to supportive care as there are no effective drug therapy options. Frontiera is developing an innovative therapeutic that addresses the root cause of this devastating medical syndrome.
VERIFIED Status:
UNVERIFIED
Address:
LAST VERIFIED:
--
Phone:
Payment Method:
Our similar businesses nearby shows similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.
Our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.
Select from over 115 networks below to view available data about this business. If this data is unavailable or inaccurate and you own or represent this business, click here for more information on how you may be able to correct it.
© Dun & Bradstreet, Inc. 2025. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.